-
1
-
-
0021339666
-
Formation and actions of leukotrienes
-
Piper P. J., Formation and actions of leukotrienes Physiological Reviews 1984 64 2 744 761
-
(1984)
Physiological Reviews
, vol.64
, Issue.2
, pp. 744-761
-
-
Piper, P.J.1
-
3
-
-
0023177955
-
Leukotrienes and lipoxins: Structures, biosynthesis, and biological effects
-
Samuelsson B., Dahlen S.-E., Lindgren J. A., Rouzer C. A., Serhan C. N., Leukotrienes and lipoxins: structures, biosynthesis, and biological effects Science 1987 237 4819 1171 1176
-
(1987)
Science
, vol.237
, Issue.4819
, pp. 1171-1176
-
-
Samuelsson, B.1
Dahlen, S.-E.2
Lindgren, J.A.3
Rouzer, C.A.4
Serhan, C.N.5
-
4
-
-
34547657273
-
Antileukotriene drugs: Clinical application, effectiveness and safety
-
Riccioni G., Bucciarelli T., Mancini B., Di Ilio C., DOrazio N., Antileukotriene drugs: clinical application, effectiveness and safety Current Medicinal Chemistry 2007 14 18 1966 1977
-
(2007)
Current Medicinal Chemistry
, vol.14
, Issue.18
, pp. 1966-1977
-
-
Riccioni, G.1
Bucciarelli, T.2
Mancini, B.3
Di Ilio, C.4
Dorazio, N.5
-
5
-
-
17444425699
-
Brief review: Advances in therapy with antileukotriene drugs
-
Riccioni G., Di Ilio C., Conti P., Theoharides T. C., DOrazio N., Brief review: advances in therapy with antileukotriene drugs Annals of Clinical and Laboratory Science 2004 34 4 379 387
-
(2004)
Annals of Clinical and Laboratory Science
, vol.34
, Issue.4
, pp. 379-387
-
-
Riccioni, G.1
Di Ilio, C.2
Conti, P.3
Theoharides, T.C.4
Dorazio, N.5
-
6
-
-
42749088012
-
Inflammatory signaling through leukotriene receptors in atherosclerosis
-
Back M., Inflammatory signaling through leukotriene receptors in atherosclerosis Current Atherosclerosis Reports 2008 10 3 244 251
-
(2008)
Current Atherosclerosis Reports
, vol.10
, Issue.3
, pp. 244-251
-
-
Back, M.1
-
7
-
-
58749083360
-
Leukotriene signaling in atherosclerosis and ischemia
-
Back M., Leukotriene signaling in atherosclerosis and ischemia Cardiovascular Drugs and Therapy 2009 23 1 41 48
-
(2009)
Cardiovascular Drugs and Therapy
, vol.23
, Issue.1
, pp. 41-48
-
-
Back, M.1
-
8
-
-
4644301666
-
The 5-lipoxygenase pathway promotes pathogenesis of hyperlipidemia- dependent aortic aneurysm
-
Zhao L., Moos M. P., Grbner R., The 5-lipoxygenase pathway promotes pathogenesis of hyperlipidemia-dependent aortic aneurysm Nature Medicine 2004 10 9 966 973
-
(2004)
Nature Medicine
, vol.10
, Issue.9
, pp. 966-973
-
-
Zhao, L.1
Moos, M.P.2
Grbner, R.3
-
9
-
-
34250835541
-
Inhibited aortic aneurysm formation in BLT1-deficient mice
-
Ahluwalia N., Lin A. Y., Tager A. M., Inhibited aortic aneurysm formation in BLT1-deficient mice The Journal of Immunology 2007 179 1 691 697
-
(2007)
The Journal of Immunology
, vol.179
, Issue.1
, pp. 691-697
-
-
Ahluwalia, N.1
Lin, A.Y.2
Tager, A.M.3
-
12
-
-
2342421274
-
Leukotriene A4 hydrolase as a target for cancer prevention and therapy
-
Chen X., Wang S., Wu N., Yang C. S., Leukotriene A4 hydrolase as a target for cancer prevention and therapy Current Cancer Drug Targets 2004 4 3 267 283
-
(2004)
Current Cancer Drug Targets
, vol.4
, Issue.3
, pp. 267-283
-
-
Chen, X.1
Wang, S.2
Wu, N.3
Yang, C.S.4
-
13
-
-
0035180314
-
12/15-lipoxygenase, oxidative modification of LDL and atherogenesis
-
Funk C. D., Cyrus T., 12/15-lipoxygenase, oxidative modification of LDL and atherogenesis Trends in Cardiovascular Medicine 2001 11 3-4 116 124
-
(2001)
Trends in Cardiovascular Medicine
, vol.11
, Issue.34
, pp. 116-124
-
-
Funk, C.D.1
Cyrus, T.2
-
14
-
-
23844530173
-
Leukotriene modifiers as potential therapeutics for cardiovascular disease
-
Funk C. D., Leukotriene modifiers as potential therapeutics for cardiovascular disease Nature Reviews Drug Discovery 2005 4 8 664 672
-
(2005)
Nature Reviews Drug Discovery
, vol.4
, Issue.8
, pp. 664-672
-
-
Funk, C.D.1
-
15
-
-
0000641581
-
Vascular endothelium in health and disease
-
New York, NY, USA Scientific American Medicine
-
Gimbrone M. A., Haber E., Vascular endothelium in health and disease Molecular Cardiovascular Medicine 1995 New York, NY, USA Scientific American Medicine 67B 70B
-
(1995)
Molecular Cardiovascular Medicine
-
-
Gimbrone, M.A.1
Haber, E.2
-
16
-
-
0002718879
-
Vascular endothelium dysfunction and the pathogenesis of atherosclerosis
-
New York, NY, USA Raven Press
-
Gimbrone M. A., Kume N., Cybulsky M. I., Weber P. C., Leaf A., Vascular endothelium dysfunction and the pathogenesis of atherosclerosis Atherosclerosis Reviews 1993 New York, NY, USA Raven Press
-
(1993)
Atherosclerosis Reviews
-
-
Gimbrone, M.A.1
Kume, N.2
Cybulsky, M.I.3
Weber, P.C.4
Leaf, A.5
-
17
-
-
0030711558
-
Nitric oxide synthases: Which, where, how, and why?
-
Michel T., Feron O., Nitric oxide synthases: which, where, how, and why? The Journal of Clinical Investigation 1997 100 9 2146 2152
-
(1997)
The Journal of Clinical Investigation
, vol.100
, Issue.9
, pp. 2146-2152
-
-
Michel, T.1
Feron, O.2
-
18
-
-
0031978582
-
Eicosanoids and iso-eicosanoids: Constitutive, inducible and transcellular biosynthesis in vascular disease
-
Maclouf J., Folco G., Patrono C., Eicosanoids and iso-eicosanoids: constitutive, inducible and transcellular biosynthesis in vascular disease Thrombosis and Haemostasis 1998 79 4 691 705
-
(1998)
Thrombosis and Haemostasis
, vol.79
, Issue.4
, pp. 691-705
-
-
MacLouf, J.1
Folco, G.2
Patrono, C.3
-
20
-
-
58649085872
-
Role of platelets in atherothrombosis
-
3 supplement
-
Jennings L. K., Role of platelets in atherothrombosis American Journal of Cardiology 2009 103 3 supplement 4A 10A
-
(2009)
American Journal of Cardiology
, vol.103
-
-
Jennings, L.K.1
-
21
-
-
52949153587
-
Arachidonic-acid-derived eicosanoids: Roles in biology and immunopathology
-
Harizi H., Corcuff J.-B., Gualde N., Arachidonic-acid-derived eicosanoids: roles in biology and immunopathology Trends in Molecular Medicine 2008 14 10 461 469
-
(2008)
Trends in Molecular Medicine
, vol.14
, Issue.10
, pp. 461-469
-
-
Harizi, H.1
Corcuff, J.-B.2
Gualde, N.3
-
22
-
-
34250852792
-
Cysteinyl-leukotrienes and their receptors in asthma and other inflammatory diseases: Critical update and emerging trends
-
Capra V., Thompson M. D., Sala A., Cole D. E., Folco G., Rovati G. E., Cysteinyl-leukotrienes and their receptors in asthma and other inflammatory diseases: critical update and emerging trends Medicinal Research Reviews 2007 27 4 469 527
-
(2007)
Medicinal Research Reviews
, vol.27
, Issue.4
, pp. 469-527
-
-
Capra, V.1
Thompson, M.D.2
Sala, A.3
Cole, D.E.4
Folco, G.5
Rovati, G.E.6
-
24
-
-
58149183694
-
IUPHAR-DB: The IUPHAR database of G protein-coupled receptors and ion channels
-
supplement 1
-
Harmar A. J., Hills R. A., Rosser E. M., IUPHAR-DB: the IUPHAR database of G protein-coupled receptors and ion channels Nucleic Acids Research 2009 37 supplement 1 D680 D685
-
(2009)
Nucleic Acids Research
, vol.37
-
-
Harmar, A.J.1
Hills, R.A.2
Rosser, E.M.3
-
25
-
-
0030976460
-
A G-protein-coupled receptor for leukotriene B4 that mediates chemotaxis
-
Yokomizo T., Izumi T., Chang K., Takuwa Y., Shimizu T., A G-protein-coupled receptor for leukotriene B4 that mediates chemotaxis Nature 1997 387 6633 620 624
-
(1997)
Nature
, vol.387
, Issue.6633
, pp. 620-624
-
-
Yokomizo, T.1
Izumi, T.2
Chang, K.3
Takuwa, Y.4
Shimizu, T.5
-
26
-
-
0034618068
-
4 receptor, BLT2: A new therapeutic target in inflammation and immunological disorders
-
4 receptor, BLT2: a new therapeutic target in inflammation and immunological disorders Journal of Experimental Medicine 2000 192 3 421 431
-
(2000)
Journal of Experimental Medicine
, vol.192
, Issue.3
, pp. 421-431
-
-
Yokomizo, T.1
Kato, K.2
Terawaki, K.3
Izumi, T.4
Shimizu, T.5
-
27
-
-
0035853806
-
4 receptor, BLT2
-
4 receptor, BLT2 The Journal of Biological Chemistry 2001 276 15 12454 12459
-
(2001)
The Journal of Biological Chemistry
, vol.276
, Issue.15
, pp. 12454-12459
-
-
Yokomizo, T.1
Kato, K.2
Hagiya, H.3
Izumi, T.4
Shimizu, T.5
-
28
-
-
0033600291
-
Characterization of the human cysteinyl leukotriene CysLT 1 receptor
-
Lynch K. R., ONeill G. P., Liu Q., Characterization of the human cysteinyl leukotriene CysLT 1 receptor Nature 1999 399 6738 789 793
-
(1999)
Nature
, vol.399
, Issue.6738
, pp. 789-793
-
-
Lynch, K.R.1
Oneill, G.P.2
Liu, Q.3
-
29
-
-
0023664204
-
Identification and characterization of leukotriene D 4 receptors and signal transduction processes in rat basophilic leukemia cells
-
Sarau H. M., Mong S., Foley J. J., Wu H. L., Crooke S. T., Identification and characterization of leukotriene D 4 receptors and signal transduction processes in rat basophilic leukemia cells The Journal of Biological Chemistry 1987 262 9 4034 4041
-
(1987)
The Journal of Biological Chemistry
, vol.262
, Issue.9
, pp. 4034-4041
-
-
Sarau, H.M.1
Mong, S.2
Foley, J.J.3
Wu, H.L.4
Crooke, S.T.5
-
31
-
-
0034596223
-
The molecular characterization and tissue distribution of the human cysteinyl leukotriene CysLT 2 receptor
-
Takasaki J., Kamohara M., Matsumoto M., The molecular characterization and tissue distribution of the human cysteinyl leukotriene CysLT 2 receptor Biochemical and Biophysical Research Communications 2000 274 2 316 322
-
(2000)
Biochemical and Biophysical Research Communications
, vol.274
, Issue.2
, pp. 316-322
-
-
Takasaki, J.1
Kamohara, M.2
Matsumoto, M.3
-
32
-
-
0033664314
-
Molecular cloning and characterization of a second human cysteinyl leukotriene receptor: Discovery of a subtype selective agonist
-
Nothacker H.-P., Wang Z., Zhu Y., Reinscheid R. K., Lin S. H. S., Civelli O., Molecular cloning and characterization of a second human cysteinyl leukotriene receptor: discovery of a subtype selective agonist Molecular Pharmacology 2000 58 6 1601 1608
-
(2000)
Molecular Pharmacology
, vol.58
, Issue.6
, pp. 1601-1608
-
-
Nothacker, H.-P.1
Wang, Z.2
Zhu, Y.3
Reinscheid, R.K.4
Lin, S.H.S.5
Civelli, O.6
-
33
-
-
34548746511
-
Leukotriene receptors: Crucial components in vascular inflammation
-
Back M., Leukotriene receptors: crucial components in vascular inflammation The Scientific World Journal 2007 7 1422 1439
-
(2007)
The Scientific World Journal
, vol.7
, pp. 1422-1439
-
-
Back, M.1
-
35
-
-
33845720603
-
Asymmetric conformational changes in a GPCR dimer controlled by G-proteins
-
Damian M., Martin A., Mesnier D., Pin J.-P., Banres J.-L., Asymmetric conformational changes in a GPCR dimer controlled by G-proteins The EMBO Journal 2006 25 24 5693 5702
-
(2006)
The EMBO Journal
, vol.25
, Issue.24
, pp. 5693-5702
-
-
Damian, M.1
Martin, A.2
Mesnier, D.3
Pin, J.-P.4
Banres, J.-L.5
-
36
-
-
0037120054
-
Intracrine cysteinyl leukotriene receptor-mediated signaling of eosinophil vesicular transport-mediated interleukin-4 secretion
-
Bandeira-Melo C., Woods L. J., Phoofolo M., Weller P. F., Intracrine cysteinyl leukotriene receptor-mediated signaling of eosinophil vesicular transport-mediated interleukin-4 secretion Journal of Experimental Medicine 2002 196 6 841 850
-
(2002)
Journal of Experimental Medicine
, vol.196
, Issue.6
, pp. 841-850
-
-
Bandeira-Melo, C.1
Woods, L.J.2
Phoofolo, M.3
Weller, P.F.4
-
37
-
-
0346787907
-
From asthma to atherosclerosis5-lipoxygenase, leukotrienes, and inflammation
-
De Caterina R., Zampolli A., From asthma to atherosclerosis5- lipoxygenase, leukotrienes, and inflammation The New England Journal of Medicine 2004 350 1 4 7
-
(2004)
The New England Journal of Medicine
, vol.350
, Issue.1
, pp. 4-7
-
-
De Caterina, R.1
Zampolli, A.2
-
38
-
-
0037372846
-
International union of pharmacology XXXVII. Nomenclature for leukotriene and lipoxin receptors
-
Brink C., Dahlen S.-E., Drazen J., International union of pharmacology XXXVII. Nomenclature for leukotriene and lipoxin receptors Pharmacological Reviews 2003 55 1 195 227
-
(2003)
Pharmacological Reviews
, vol.55
, Issue.1
, pp. 195-227
-
-
Brink, C.1
Dahlen, S.-E.2
Drazen, J.3
-
40
-
-
0347418277
-
Arachidonate 5-lipoxygenase promoter genotype, dietary arachidonic acid, and atherosclerosis
-
Dwyer J. H., Allayee H., Dwyer K. M., Arachidonate 5-lipoxygenase promoter genotype, dietary arachidonic acid, and atherosclerosis The New England Journal of Medicine 2004 350 1 29 37
-
(2004)
The New England Journal of Medicine
, vol.350
, Issue.1
, pp. 29-37
-
-
Dwyer, J.H.1
Allayee, H.2
Dwyer, K.M.3
-
41
-
-
10744220794
-
The gene encoding 5-lipoxygenase activating protein confers risk of myocardial infarction and stroke
-
Helgadottir A., Manolescu A., Thorleifsson G., The gene encoding 5-lipoxygenase activating protein confers risk of myocardial infarction and stroke Nature Genetics 2004 36 3 233 239
-
(2004)
Nature Genetics
, vol.36
, Issue.3
, pp. 233-239
-
-
Helgadottir, A.1
Manolescu, A.2
Thorleifsson, G.3
-
42
-
-
0036124634
-
Leukotriene B4 receptor antagonism reduces monocytic foam cells in mice
-
Aiello R. J., Bourassa P.-A., Lindsey S., Weng W., Freeman A., Showell H. J., Leukotriene B4 receptor antagonism reduces monocytic foam cells in mice Arteriosclerosis, Thrombosis, and Vascular Biology 2002 22 3 443 449
-
(2002)
Arteriosclerosis, Thrombosis, and Vascular Biology
, vol.22
, Issue.3
, pp. 443-449
-
-
Aiello, R.J.1
Bourassa, P.-A.2
Lindsey, S.3
Weng, W.4
Freeman, A.5
Showell, H.J.6
-
43
-
-
1042268024
-
Role of leukotriene B4 receptors in the development of atherosclerosis: Potential mechanisms
-
Subbarao K., Jala V. R., Mathis S., Role of leukotriene B4 receptors in the development of atherosclerosis: potential mechanisms Arteriosclerosis, Thrombosis, and Vascular Biology 2004 24 2 369 375
-
(2004)
Arteriosclerosis, Thrombosis, and Vascular Biology
, vol.24
, Issue.2
, pp. 369-375
-
-
Subbarao, K.1
Jala, V.R.2
Mathis, S.3
-
44
-
-
64549104987
-
Three months of treatment with 5-lipoxygenase inhibitor VIA-2291 in patients with recent acute coronary syndrome
-
Tardif J. C., LAllier P. L., Ibhraim R., Three months of treatment with 5-lipoxygenase inhibitor VIA-2291 in patients with recent acute coronary syndrome Circulation 2008 118 2309 2317
-
(2008)
Circulation
, vol.118
, pp. 2309-2317
-
-
Tardif, J.C.1
Lallier, P.L.2
Ibhraim, R.3
-
45
-
-
36849083574
-
Expression, purification and crystallization of human 5-lipoxygenase-activating protein with leukotriene-biosynthesis inhibitors
-
Xu S., McKeever B. M., Wisniewski D., Expression, purification and crystallization of human 5-lipoxygenase-activating protein with leukotriene-biosynthesis inhibitors Acta Crystallographica Section F 2007 63 12 1054 1057
-
(2007)
Acta Crystallographica Section F
, vol.63
, Issue.12
, pp. 1054-1057
-
-
Xu, S.1
McKeever, B.M.2
Wisniewski, D.3
-
46
-
-
34547560098
-
Crystal structure of inhibitor-bound human 5-lipoxygenase-activating protein
-
Ferguson A. D., McKeever B. M., Xu S., Crystal structure of inhibitor-bound human 5-lipoxygenase-activating protein Science 2007 317 5837 510 512
-
(2007)
Science
, vol.317
, Issue.5837
, pp. 510-512
-
-
Ferguson, A.D.1
McKeever, B.M.2
Xu, S.3
-
49
-
-
0031927443
-
Safety and clinical efficacy of zileuton in patients with chronic asthma
-
supplement 6
-
Lazarus S. C., Lee T., Kemp J. P., Safety and clinical efficacy of zileuton in patients with chronic asthma American Journal of Managed Care 1998 4 supplement 6 841 848
-
(1998)
American Journal of Managed Care
, vol.4
, pp. 841-848
-
-
Lazarus, S.C.1
Lee, T.2
Kemp, J.P.3
-
50
-
-
0028128943
-
The oxidation hypothesis of atherosclerosis
-
Witztum J. L., The oxidation hypothesis of atherosclerosis The Lancet 1994 344 8925 793 795
-
(1994)
The Lancet
, vol.344
, Issue.8925
, pp. 793-795
-
-
Witztum, J.L.1
-
51
-
-
0033552883
-
Atherosclerosisan inflammatory disease
-
Ross R., Atherosclerosisan inflammatory disease The New England Journal of Medicine 1999 340 2 115 126
-
(1999)
The New England Journal of Medicine
, vol.340
, Issue.2
, pp. 115-126
-
-
Ross, R.1
-
52
-
-
0034648768
-
Atherosclerosis
-
Lusis A. J., Atherosclerosis Nature 2000 407 233 241
-
(2000)
Nature
, vol.407
, pp. 233-241
-
-
Lusis, A.J.1
-
53
-
-
0035920262
-
Genetic locus in mice that blocks development of atherosclerosis despite extreme hyperlipidemia
-
Mehrabian M., Wong J., Wang X., Genetic locus in mice that blocks development of atherosclerosis despite extreme hyperlipidemia Circulation Research 2001 89 2 125 130
-
(2001)
Circulation Research
, vol.89
, Issue.2
, pp. 125-130
-
-
Mehrabian, M.1
Wong, J.2
Wang, X.3
-
54
-
-
0037178728
-
Identification of 5-lipoxygenase as a major gene contributing to atherosclerosis susceptibility in mice
-
Mehrabian M., Allayee H., Wong J., Identification of 5-lipoxygenase as a major gene contributing to atherosclerosis susceptibility in mice Circulation Research 2002 91 2 120 126
-
(2002)
Circulation Research
, vol.91
, Issue.2
, pp. 120-126
-
-
Mehrabian, M.1
Allayee, H.2
Wong, J.3
-
56
-
-
0347418277
-
Arachidonate 5-lipoxygenase promoter genotype, dietary arachidonic acid, and atherosclerosis
-
Dwyer J. H., Allayee H., Dwyer K. M., Arachidonate 5-lipoxygenase promoter genotype, dietary arachidonic acid, and atherosclerosis The New England Journal of Medicine 2004 350 1 29 37
-
(2004)
The New England Journal of Medicine
, vol.350
, Issue.1
, pp. 29-37
-
-
Dwyer, J.H.1
Allayee, H.2
Dwyer, K.M.3
-
57
-
-
10744220794
-
The gene encoding 5-lipoxygenase activating protein confers risk of myocardial infarction and stroke
-
Helgadottir A., Manolescu A., Thorleifsson G., The gene encoding 5-lipoxygenase activating protein confers risk of myocardial infarction and stroke Nature Genetics 2004 36 3 233 239
-
(2004)
Nature Genetics
, vol.36
, Issue.3
, pp. 233-239
-
-
Helgadottir, A.1
Manolescu, A.2
Thorleifsson, G.3
-
58
-
-
13844289142
-
Association between the gene encoding 5-lipoxygenase-activating protein and stroke replicated in a Scottish population
-
Helgadottir A., Gretarsdottir S., St. Clair D., Association between the gene encoding 5-lipoxygenase-activating protein and stroke replicated in a Scottish population American Journal of Human Genetics 2005 76 3 505 509
-
(2005)
American Journal of Human Genetics
, vol.76
, Issue.3
, pp. 505-509
-
-
Helgadottir, A.1
Gretarsdottir, S.2
St. Clair, D.3
-
59
-
-
29444444748
-
A variant of the gene encoding leukotriene A4 hydrolase confers ethnicity-specific risk of myocardial infarction
-
Helgadottir A., Manolescu A., Helgason A., A variant of the gene encoding leukotriene A4 hydrolase confers ethnicity-specific risk of myocardial infarction Nature Genetics 2006 38 1 68 74
-
(2006)
Nature Genetics
, vol.38
, Issue.1
, pp. 68-74
-
-
Helgadottir, A.1
Manolescu, A.2
Helgason, A.3
-
60
-
-
23944487989
-
The 5-lipoxygenase pathway in arterial wall biology and atherosclerosis
-
Lotzer K., Funk C. D., Habenicht A. J. R., The 5-lipoxygenase pathway in arterial wall biology and atherosclerosis Biochimica et Biophysica Acta 2005 1736 1 30 37
-
(2005)
Biochimica et Biophysica Acta
, vol.1736
, Issue.1
, pp. 30-37
-
-
Lotzer, K.1
Funk, C.D.2
Habenicht, A.J.R.3
-
61
-
-
34247548667
-
5-lipoxygenase: Regulation and possible involvement in atherosclerosis
-
Rdmark O., Samuelsson B., 5-lipoxygenase: regulation and possible involvement in atherosclerosis Prostaglandins and Other Lipid Mediators 2007 83 3 162 174
-
(2007)
Prostaglandins and Other Lipid Mediators
, vol.83
, Issue.3
, pp. 162-174
-
-
Rdmark, O.1
Samuelsson, B.2
-
62
-
-
62649157212
-
Genetic and pharmacological inhibition of the 5-lipoxygenase/leukotriene pathway in atherosclerotic lesion development in ApoE deficient mice
-
Cao R. Y., St. Amand T., Grbner R., Habenicht A. J.R., Funk C. D., Genetic and pharmacological inhibition of the 5-lipoxygenase/leukotriene pathway in atherosclerotic lesion development in ApoE deficient mice Atherosclerosis 2009 203 2 395 400
-
(2009)
Atherosclerosis
, vol.203
, Issue.2
, pp. 395-400
-
-
Cao, R.Y.1
St. Amand, T.2
Grbner, R.3
Habenicht, A.J.R.4
Funk, C.D.5
-
63
-
-
18244403498
-
Effects of a 5-lipoxygenase-activating protein inhibitor on biomarkers associated with risk of myocardial infarction: A randomized trial
-
Hakonarson H., Thorvaldsson S., Helgadottir A., Effects of a 5-lipoxygenase-activating protein inhibitor on biomarkers associated with risk of myocardial infarction: a randomized trial Journal of the American Medical Association 2005 293 18 2245 2256
-
(2005)
Journal of the American Medical Association
, vol.293
, Issue.18
, pp. 2245-2256
-
-
Hakonarson, H.1
Thorvaldsson, S.2
Helgadottir, A.3
-
64
-
-
33646814032
-
Role of FLAP and PDE4D in myocardial infarction and stroke: Target discovery and future treatment options
-
Hakonarson H., Role of FLAP and PDE4D in myocardial infarction and stroke: target discovery and future treatment options Current Treatment Options in Cardiovascular Medicine 2006 8 3 183 192
-
(2006)
Current Treatment Options in Cardiovascular Medicine
, vol.8
, Issue.3
, pp. 183-192
-
-
Hakonarson, H.1
-
66
-
-
34347203723
-
Myeloperoxidase aids prognostication together with N-terminal pro-B-type natriuretic peptide in high-risk patients with acute ST elevation myocardial infarction
-
Khan S. Q., Kelly D., Quinn P., Davies J. E., Ng L. L., Myeloperoxidase aids prognostication together with N-terminal pro-B-type natriuretic peptide in high-risk patients with acute ST elevation myocardial infarction Heart 2007 93 7 826 831
-
(2007)
Heart
, vol.93
, Issue.7
, pp. 826-831
-
-
Khan, S.Q.1
Kelly, D.2
Quinn, P.3
Davies, J.E.4
Ng, L.L.5
-
67
-
-
33847615662
-
Leukotrienes: Potential therapeutic targets in cardiovascular diseases
-
Back M., Leukotrienes: potential therapeutic targets in cardiovascular diseases Bulletin de lAcademie Nationale de Medecine 2006 190 7 1511 1518
-
(2006)
Bulletin de LAcademie Nationale de Medecine
, vol.190
, Issue.7
, pp. 1511-1518
-
-
Back, M.1
|